Blue Light Cystoscopy With Cysview® Registry

• Status: Recruiting
• Trial end date: 2025-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Photocure
• Collaborator: KARL STORZ Endoscopy-America, Inc.
• Treatments: Aminolevulinic Acid

Criteria

Inclusion Criteria:

• Adult >18 years old

• Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy

Exclusion Criteria:

• Porphyria

• Gross hematuria

• Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives